Karo Pharma Profile

4.00
USD 0.45  12.68%
100%
50%

Karo Pharma Summary

Karo Pharma AB (KARBF) is traded on OTC Market in USA. It is located in Nybrokajen 7 and employs 39 people. The company currently falls under 'Small-Cap' category with current market capitalization of 552.64 M. Karo Pharma AB has 82.17 M outstanding shares. KARO BIO AB has accumulated about 99.9 M in cash with 3.99 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22.
Check Karo Pharma Probability Of Bankruptcy

Key Fundamentals

Karo Pharma Against Markets

Current Ratings

Karo Pharma 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
2 
Chance of
Financial Distress (0 to 100%)
68 
Equity ratings for Karo Pharma AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Karo Pharma AB , a healthcare company, develops and markets products for elderly people in Sweden, Norway, Denmark, and Finland. Karo Pharma AB was founded in 1987 and is based in Stockholm, Sweden. Karo Pharma is traded on OTC Market in USA. more
NameKaro Pharma AB
CEOPeter BlomView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressNybrokajen 7
ExchangeOTC Market
SectorHealthcare
BenchmarkDOW
Websitewww.karopharma.se
Phone46 1 03 30 23 10
CurrencyUSD - US Dollar

Karo Pharma Corporate Directors

PerAnders Johansson Independent Director
Jean Lycke Director
Marianne Hamilton Director
Please see also Stocks Correlation. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.